E-News - May 2020
Alliance Foundation Special Projects Allocation


The Alliance for Clinical Trials in Oncology Foundation has recently selected 10 Alliance investigators to receive funding awards through the Foundation's Special Projects Allocation. The Foundation has made these funds available to support research focused on addressing high-priority research areas defined during the Alliance Scientific Strategic Retreat every two years.   
Every two years, Alliance leaders participate in a scientific strategic retreat, during which a number of research priorities are defined. The goal of these priorities is to focus innovation by Alliance scientific committees on a few strategic areas, with the expectation that attention to these priorities will challenge researchers to move beyond what is currently possible and accelerate the development of new treatments, cancer control approaches, and cancer care delivery results. These strategic priorities generally focus upon fostering engagement of new disciplines or technologies relevant to Alliance research, or upon work to improve the design and implementation of Alliance clinical trials.  
Alliance strategic priorities announced in November 2018 included: 1) building an infrastructure to enable studies improving/defining the value of cancer care; 2) developing blood-based biomarkers to address treatment response and characterize treatment resistance; 3) developing treatments for tumor genomic subsets: e.g., design an Alliance strategy based upon lessons learned from MATCH and TAPUR; and 4) simplifying data requirements and data collection.

Alliance for Clinical Trials in Oncology Foundation
Special Projects Allocation Recipients























To learn more about the Alliance for Clinical Trials in Oncology Foundation Special Projects Allocation, visit the Alliance Awards webpage.